Publication:
Outcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared

cris.virtual.author-orcid0000-0001-8191-2789
cris.virtual.author-orcid0000-0001-7462-5132
cris.virtualsource.author-orcid859e7994-7449-445d-ae5a-38777419f1e0
cris.virtualsource.author-orcida47a659b-5a23-43fa-86e3-f9401108114c
cris.virtualsource.author-orcidb256b53c-3915-4d75-8048-1c3f46cbbb42
datacite.rightsopen.access
dc.contributor.authorLabhardt, Niklaus Daniel
dc.contributor.authorKeiser, Olivia
dc.contributor.authorSello, Motlalepula
dc.contributor.authorLejone, Thabo Ishmael
dc.contributor.authorPfeiffer, Karolin
dc.contributor.authorDavies, Mary-Ann
dc.contributor.authorEgger, Matthias
dc.contributor.authorEhmer, Jochen
dc.contributor.authorWandeler, Gilles
dc.date.accessioned2024-10-14T15:56:41Z
dc.date.available2024-10-14T15:56:41Z
dc.date.issued2013-11-21
dc.description.abstractIntroduction: Lesotho was among the first countries to adopt decentralization of care from hospitals to nurse-led health centres (HCs) to scale up the provision of antiretroviral therapy (ART). We compared outcomes between patients who started ART at HCs and hospitals in two rural catchment areas in Lesotho. Methods: The two catchment areas comprise two hospitals and 12 HCs. Patients ≥16 years starting ART at a hospital or HC between 2008 and 2011 were included. Loss to follow-up (LTFU) was defined as not returning to the facility for ≥180 days after the last visit, no follow-up (no FUP) as not returning after starting ART, and retention in care as alive and on ART at the facility. The data were analysed using logistic regression, competing risk regression and Kaplan-Meier methods. Multivariable analyses were adjusted for sex, age, CD4 cell count, World Health Organization stage, catchment area and type of ART. All analyses were stratified by gender. Results: Of 3747 patients, 2042 (54.5%) started ART at HCs. Both women and men at hospitals had more advanced clinical and immunological stages of disease than those at HCs. Over 5445 patient-years, 420 died and 475 were LTFU. Kaplan-Meier estimates for three-year retention were 68.7 and 69.7% at HCs and hospitals, respectively, among women (p=0.81) and 68.8% at HCs versus 54.7% at hospitals among men (p<0.001). These findings persisted in adjusted analyses, with similar retention at HCs and hospitals among women (odds ratio (OR): 0.89, 95% confidence interval (CI): 0.73-1.09) and higher retention at HCs among men (OR: 1.53, 95% CI: 1.20-1.96). The latter result was mainly driven by a lower proportion of patients LTFU at HCs (OR: 0.68, 95% CI: 0.51-0.93). Conclusions: In rural Lesotho, overall retention in care did not differ significantly between nurse-led HCs and hospitals. However, men seemed to benefit most from starting ART at HCs, as they were more likely to remain in care in these facilities compared to hospitals.
dc.description.noteLabhardt and Wandeler contributed equally to this work.
dc.description.sponsorshipUniversitätsklinik für Infektiologie
dc.description.sponsorshipInstitut für Sozial- und Präventivmedizin (ISPM)
dc.identifier.doi10.7892/boris.41420
dc.identifier.pmid24267671
dc.identifier.publisherDOI10.7448/IAS.16.1.18616
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/113298
dc.language.isoen
dc.publisherBioMed Central
dc.relation.ispartofJournal of the International AIDS Society
dc.relation.issn1758-2652
dc.relation.organizationInstitute of Social and Preventive Medicine
dc.relation.organizationClinic of Infectiology
dc.subjectantiretroviral treatment
dc.subjectdecentralization
dc.subjectrural Southern Africa
dc.subjectretention in care
dc.subjecttask shifting
dc.subjectnurse-based care
dc.subjectHIV
dc.subject.ddc300 - Social sciences, sociology & anthropology::360 - Social problems & social services
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleOutcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
dspace.file.typeimage
dspace.file.typeimage
oaire.citation.issue1
oaire.citation.startPage18616
oaire.citation.volume16
oairecerif.author.affiliationInstitut für Sozial- und Präventivmedizin (ISPM)
oairecerif.author.affiliationInstitut für Sozial- und Präventivmedizin (ISPM)
oairecerif.author.affiliationUniversitätsklinik für Infektiologie
oairecerif.author.affiliation2Institut für Sozial- und Präventivmedizin (ISPM)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2017-09-12 04:35:44
unibe.description.ispublishedpub
unibe.eprints.legacyId41420
unibe.journal.abbrevTitleJ INT AIDS SOC
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 3 of 3
Name:
Labhardt JIntAIDSSoc 2013.pdf
Size:
356.98 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published
Name:
Labhardt JIntAIDSSoc 2013_supplfigure1.pdf
Size:
56.15 KB
Format:
Adobe Portable Document Format
File Type:
image
License:
https://creativecommons.org/licenses/by/4.0
Content:
metadata
Name:
Labhardt JIntAIDSSoc 2013_webtable1.pdf
Size:
95.32 KB
Format:
Adobe Portable Document Format
File Type:
image
License:
https://creativecommons.org/licenses/by/4.0
Content:
metadata

Collections